Spotlight

UCL cancer immunotherapy company, Autolus, launches with £30m investment

A new UCL spin-out company – Autolus – is being launched today to develop and commercialise a new generation of engineered T-cell therapies for haematological and solid tumours, with the backing of £30m in investment from healthcare investment company Syncona.

Find out more



follow us on twitter


Archive of News

<< 2011 Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec 2013 >>

5 October 2012: Journey to the Dragon’s Den

It wasn’t a destination that Art Stavenka, 26, had ever envisaged when his road to entrepreneurship began at UCL: a slot on one of the most watched searches for entrepreneurial talent in the UK, Dragon’s Den.
More...

<< 2011 Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec 2013 >>